Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

Zomedica

ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced it has entered into a license and supply agreement with Celsee, Inc. (“Celsee”), an innovator of progressive rare cell capture, characterization and retrieval products in the emerging field of liquid biopsy. Under the terms …

Zomedica Announces Achievement of Therapeutic Development Milestones

Zomedica

ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a development update on the Company’s four therapeutic candidates for use in companion animals, namely dogs and cats. “We are pleased that we have achieved the milestones we established earlier this year,” stated Gerald …

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

Zomedica

ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today announced that the NYSE American has advised that trading of the Company’s common shares under the symbol “ZOM” will commence on November 21, 2017, subject to the effectiveness of the Company’s registration statement …

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017

Zomedica

ANN ARBOR, Mich., Nov. 8, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the Jefferies 2017 London Healthcare Conference on November 15 in London, UK, and at the LD Micro Main Event 2017 on December 5 in Los Angeles, CA. Chief Executive Officer Gerald Solensky …